Til
NTNUs
main page NTNU's førsteside Faculty Natural
Science and Technology Department
of Biotechnology
About logo

History (in Norw.)

Organisation and groups

Personnel

Research projects

Publications

Ph.D. theses

Laboratories

Patents

Media attention

M.Sc. program

Ph.D. positions

Post doc. positions

Industry

Innovation

Evaluations

Conferences

 

NOBIPOL: The Norwegian Biopolymer Laboratory

  Center for Biopolymer Engineering at NTNU

NEWS!

9 Jan 200). Yrr Mörch wins Tekna award for young researchers

23 Oct 2008: Dr. Ingvild Haug received innovation prize: (Adresseavisen TV), (Namdalsavisa)

22 Oct 2008: Post.doc. position on hemicelluloses

Mark-Houwink parameters of alginate.

15 March 2007: Marit Sletmoen received Young Researchers award (DKNVS)

7 Jan. 2007: Professor Gudmund Skjåk-Bræk takes over as Director of NOBIPOL

23 Nov: Chitosan article accepted for publication in PNAS (co-authors: Sikorski, Vårum)

 

Our vision
 

NOBIPOL is a multidisciplinary research group within NTNU devoted to the field Biopolymer Engineering, with main focus on the science and technologies of marine polysaccharides, in particular alginates and chitosans.

On the basis of more than 50 years of contineous research in the field NOBIPOL posesses unmatched competence and experience in all aspects of science and technology of marine polysaccharides.

The current activities of NOBIPOL take place within the Department of Biotechnology, the Department of Physics, and the Department of Cancer Research and Molecular Medicine.

Professors Olav Smidsrød and Terje Espevik, are both on the prestigeous list of Highly Cited Researchers (ISI Web of Knowledge).

Research areas:

Biopolymer Engineering

Medical biotechnology

Alginates

Chitosans

Sphagnan

Marine collagens

Carrageenans and agar

Scleroglucan

Chitosan-based nanoparticles for non-viral gene delivery

Methods

   
 

2006 - commercial highlights:

Two novel companies (start-ups) based on NOBIPOL research: Vireo AS (Sphagnan technology) and AlgiPharma AS (alginate technologies for cystic fibrosis and wound healing).

Chitosan oligomers for gene delivery developed by NOBIPOL commercialised by FMC NovaMatrix

Cosmetic product based on marine collagen developed by NOBIPOL commercialised by Kilda Biolink ASA

Alginate based fish feed product for immune stimulation based on NOBIPOL research commercialised by BioMar

  XXIV International Carbohydrate Symposium, Oslo, July 27 - August ,1 2008
News archive
 
 
 
 
 
 


Editor: Bjørn E. Christensen, Contact address : B.Christensen@biotech.ntnu.no, Updated: 25.10.2009